News
The U.S. Treasury accuses CIBanco and Intercam Banco of money laundering and facilitating payments related to fentanyl.
3h
TipRanks on MSNAstraZeneca’s New Study on AZD5492: A Potential Game-Changer for Autoimmune DiseasesAstraZeneca has launched a Phase I clinical study titled An Open-label, Phase I Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD5492 Followi ...
Detalimogene voraplasmid gains FDA RMAT designation, showcasing a 71% response rate in treating high-risk, BCG-unresponsive ...
President Bola Ahmed Tinubu has called for a collective national effort in combating substance abuse and illicit drug ...
The US Food and Drug Administration (FDA) has approved the belimumab 200 mg/mL autoinjector for children aged 5 years of older with active lupus nephritis (LN) who are receiving standard therapy.
A team of doctors at Michigan Medicine have successfully treated a child in severe septic shock and multiorgan failure with ...
Cohen, E. and Kubinak, N. (2025) A Rare Presentation of Cavernous Sinus Thrombosis in a Young Female. Surgical Science, 16, ...
Benlysta is supplied as a single-dose prefilled autoinjector or prefilled syringe containing 200mg/mL of belimumab for SC use. The prefilled syringe has not been studied in pediatric patients aged ...
In a heated hearing, Kari Lake, the Trump ally in charge of the federally funded international broadcasting network, called ...
MIAMI, FL / ACCESS Newswire / June 25, 2025 / iTolerance, Inc. (“iTolerance” or the “Company”), an early-stage privately-held ...
Finding an effective, safe medication to control itch is essential to maximize patient comfort. Because Zenrelia does not require a loading dose and is administered once daily, Zenrelia may help impro ...
Only five days after FDA approval of Yutrepia, Liquidia announced its first commercial shipment of the therapy, making prescriptions available to patients at specialty pharmacies. “We have moved with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results